OsmoPrep & Visicol Side Effects May Include Blocking Kidney Function
Free Case Evaluation: If you or a loved one has developed acute phosphate nephropathy or any other form of kidney injury after using Visicol, OsmoPrep, or Fleet Phospho-soda, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
What’s the problem?
Visicol, OsmoPrep, or Fleet Phospho-soda side effects vary widely from person to person, but the most common adverse side effects include:
- Abdominal bloating & pain
- Severe kidney damage
- Acute phosphate nephropathy
- Renal failure
- Facial swelling
- Throat tightness
Seizures and arrhythmia have also been reported, as well as indications of renal impairment, increased blood urea nitrogen (BUN), increased creatine, nephrocalcinosis, and renal tubular necrosis. Because of the risk of dehydration, patients are always advised to take the medication as directed. Common side effects of dehydration include dizziness, malaise, vomiting, and headache.
Patients with pre-existing conditions are warned not to take the drug due to higher incidence of these complications. Some high-risk demographics include individuals with heart problems, bowel diseases, eating disorders, diabetes, kidney disease, chronic stomach pain, severe constipation, and those who take medication for stomach pain, severe constipation, and those who take medication for blood pressure, heart disease, or kidney disease. Additionally, many drugs may interact with the bowel prep prescription, including narcotics, diuretics, NSAIDs, antibiotics, antidepressants, anti-nausea medications, anti-psychotics, blood pressure medications, and some common migraine drugs.
Do I have an OsmoPrep, Visicol or Fleet Phospho-soda Kidney Injury Lawsuit?
The Defective Drug & Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Acute Phosphate Nephropathy lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.